Clik here to view.
Beyond Glivec : Balancing innovation and public health
I’d like to introduce a guest column by Dr Kristina Lybecker, Associate Professor of Economics at Colorado College in Colorado Springs. Kristina is an economist with a PhD from the University of...
View ArticleClik here to view.
What does Glivec ruling imply for generics? My piece in Sunday ET
In case some of you were waiting for Apothecury’s take on the Glivec judgement, I was waiting for this piece that I did for the Sunday Economic Times to be published. In a nutshell, in the article I...
View ArticleClik here to view.
India and drug #patents : The Ghost of #Glivec haunts #Sovaldi
Apothecurry welcomes back guest columnist Dr Kristina Lybecker. Her latest column is an elegantly simple “where the rubber hits the road” exposition of the recent rejection of patents on US biopharma...
View ArticleClik here to view.
India and drug #patents : The Ghost of #Glivec haunts #Sovaldi
Apothecurry welcomes back guest columnist Dr Kristina Lybecker. Her latest column is an elegantly simple “where the rubber hits the road” exposition of the recent rejection of patents on US biopharma...
View ArticleClik here to view.
India and drug #patents : The Ghost of #Glivec haunts #Sovaldi
Apothecurry welcomes back guest columnist Dr Kristina Lybecker. Her latest column is an elegantly simple “where the rubber hits the road” exposition of the recent rejection of patents on US biopharma...
View Article
